Groowe Groowe / Newsroom / TMO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TMO News

Thermo Fisher Scientific, Inc.

Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry

globenewswire.com
TMO MRK DHR ANTX

Global Human Osteoblasts Market Report 2026 | Capitalize on $53.09 Billion Revenue Share by 2030 as Merck KGaA, Thermo Fisher Scientific, Lonza and STEMCELL Lead the Industry

globenewswire.com
MRK TMO

Human Plasma Like Medium Market Global Report 2026 | Capitalize on 8.6% CAGR as Thermo Fisher Scientific, Sartorius, Sigma Aldrich and HiMedia Advance IVD and Gene Therapy

globenewswire.com
TMO

Disposable Specimen Container Market Forecast Report 2026-2030 | Capitalize on Sterile Automation and $3.97B Demand with Leading Players Thermo Fisher, Cardinal Health, SARSTEDT and Greiner Bio-One

globenewswire.com
TMO

Global Nano Bioreactor Market Report 2026: Size, Share, Trends and Forecast to 2030 | Capitalize on 12% CAGR with Leading Players Thermo Fisher Scientific, Danaher, Lonza, Cytiva and Sartorius

globenewswire.com
TMO DHR

Ultima Genomics Launches Paired-End Sequencing and Solaris 2.0 Max at ASHG 2026, Doubling Output and Enabling the $60 Genome

prnewswire.com
TMO GOOG NVDA

The Consortium for Top-Down Proteomics is now The Proteoform Alliance, with the Expanded Mission to Unlock the Full Potential of Proteoform Biology

globenewswire.com
TMO BRKR LLY PFE A QSI

Global PARP Inhibitor Biomarkers Market Size, Share, Growth, Trends, and Forecast, 2026 to 2034 | Precision Oncology and HRD Testing Fuel 8.6% CAGR

globenewswire.com
A BIIB ILMN LH SWX TMO MYGN QGEN NEO

Global Viral Vector and Plasmid DNA Manufacturing Market, 7th Edition: Forecast to 2035 | 9.73% CAGR Unlocks USD 2.16 Billion CMO and Gene Therapy Opportunity

globenewswire.com
CRL CAT TMO NVS BNTX SNY

Global Single Use Assemblies Market - Forecast 2026-2032 | USD 19.18 Billion Opportunity as Biologics, Closed Processing, and AI Adoption Fuel 12.52% CAGR

globenewswire.com
AVTR CLVT DHR PARK REGN RGEN TMO